ArticleFrontiers in oncology2024

Case report: complete long-lasting response to multimodal third line treatment with neurosurgical resection, carmustine wafer implantation and dabrafenib plus trametinib in a

Barbara Castelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.